Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CLINICAL APPLICATION OF APOE IN ALZHEIMER’S PREVENTION: A PRECISION MEDICINE APPROACH
Cara Berkowitz, Lisa Mosconi, Aneela Rahman, et al.
The Journal of Prevention of Alzheimer s Disease (2018) Vol. 5, Iss. 4, pp. 245-252
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Sex and Gender Driven Modifiers of Alzheimer’s: The Role for Estrogenic Control Across Age, Race, Medical, and Lifestyle Risks
Aneela Rahman, H.C. Jackson, Hollie Hristov, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 138
Diabetes as a risk factor for Alzheimer’s disease in the Middle East and its shared pathological mediators
Richard L. Jayaraj, Sheikh Azimullah, Rami Beiram
Saudi Journal of Biological Sciences (2019) Vol. 27, Iss. 2, pp. 736-750
Open Access | Times Cited: 80
APOE Genotype and Alzheimer’s Disease: The Influence of Lifestyle and Environmental Factors
Efthalia Angelopoulou, Yam Nath Paudel, Sokratis G. Papageorgiou, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 15, pp. 2749-2764
Closed Access | Times Cited: 61
Research gaps and opportunities in precision nutrition: an NIH workshop report
Bruce Y. Lee, José M. Ordovás, Elizabeth J. Parks, et al.
American Journal of Clinical Nutrition (2022) Vol. 116, Iss. 6, pp. 1877-1900
Open Access | Times Cited: 43
Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review
Nicola Coley, Caroline Giulioli, Paul Aisen, et al.
Ageing Research Reviews (2022) Vol. 82, pp. 101777-101777
Open Access | Times Cited: 39
Emerging applications of machine learning in genomic medicine and healthcare
Narjice Chafai, L. Bonizzi, Sara Botti, et al.
Critical Reviews in Clinical Laboratory Sciences (2023) Vol. 61, Iss. 2, pp. 140-163
Closed Access | Times Cited: 30
Genetic architecture of common non-Alzheimer’s disease dementias
Rita Guerreiro, Elizabeth Gibbons, Miguel Tábuas‐Pereira, et al.
Neurobiology of Disease (2020) Vol. 142, pp. 104946-104946
Open Access | Times Cited: 39
Searching for responders to multidomain dementia prevention in late life: A pooled analysis of individual participant data from the MAPT and preDIVA trials
Nicola Coley, Marieke P. Hoevenaar‐Blom, Jason Shourick, et al.
Alzheimer s & Dementia (2025)
Open Access
Clinical investigation cases studies and critical thinking problem approaches
HENRY M ZEIDAN, IMAN H ZEIDAN
Elsevier eBooks (2025), pp. 175-263
Closed Access
Predicting conversion to Alzheimer’s disease in individuals with Mild Cognitive Impairment using clinically transferable features
Ingrid Rye, Alexandra Vik, Marek Kociński, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Association of Diet Quality and Vegetable Variety with the Risk of Cognitive Decline in Chinese Older Adults
Yi‐Chun Chou, Meei‐Shyuan Lee, Jeng‐Min Chiou, et al.
Nutrients (2019) Vol. 11, Iss. 7, pp. 1666-1666
Open Access | Times Cited: 30
Dementia Prevention in Clinical Practice
Kellyann Niotis, Kiarra Akiyoshi, Caroline Carlton, et al.
Seminars in Neurology (2022) Vol. 42, Iss. 05, pp. 525-548
Open Access | Times Cited: 16
A lifetime perspective on risk factors for cognitive decline with a special focus on early events
H. Georg Kuhn, Simon Skau, Jenny Nyberg
Cerebral Circulation - Cognition and Behavior (2024) Vol. 6, pp. 100217-100217
Open Access | Times Cited: 3
Traumatic Brain Injury Exposure Lowers Age of Cognitive Decline in AD and Non-AD Conditions
Diego Iacono, Sorana Raiciulescu, Cara Olsen, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 21
Diagnóstico da doença de Alzheimer: recomendações do Departamento Científico de Neurologia Cognitiva e do Envelhecimento da Academia Brasileira de Neurologia
Lucas Porcello Schilling, Márcio Luiz Figueredo Balthazar, Márcia Radanovic, et al.
Dementia & Neuropsychologia (2022) Vol. 16, Iss. 3 suppl 1, pp. 25-39
Open Access | Times Cited: 14
Independent and joint effects of vascular and cardiometabolic risk factor pairs for risk of all-cause dementia: a prospective population-based study
C. Elizabeth Shaaban, Yichen Jia, Chung‐Chou H. Chang, et al.
International Psychogeriatrics (2019) Vol. 31, Iss. 10, pp. 1421-1432
Open Access | Times Cited: 23
Pathways of Prevention: A Scoping Review of Dietary and Exercise Interventions for Neurocognition
Patrick J. Smith
Brain Plasticity (2019) Vol. 5, Iss. 1, pp. 3-38
Open Access | Times Cited: 22
Potential Therapeutic Approaches to Alzheimer’s Disease By Bioinformatics, Cheminformatics And Predicted Adme-Tox Tools
Speranța Avram, Maria Mernea, Carmen Limban, et al.
Current Neuropharmacology (2019) Vol. 18, Iss. 8, pp. 696-719
Open Access | Times Cited: 20
Genetic Risk Factors for Alzheimer's Disease in Racial/Ethnic Minority Populations in the U.S.: A Scoping Review
Lindsey Rubin, Lucy Annang Ingram, Nicholas Resciniti, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 17
Diagnosis of Alzheimer’s disease: recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology
Lucas Porcello Schilling, Márcio Luiz Figueredo Balthazar, Márcia Radanovic, et al.
Dementia & Neuropsychologia (2022) Vol. 16, Iss. 3 suppl 1, pp. 25-39
Open Access | Times Cited: 12
A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease
Margherita Squillario, Giulia Abate, Federico Tomasi, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 16
Alzheimer's disease: an epidemiological analysis over the number of hospitalizations and deaths in Brazil
Eduardo Cattapan Piovesan, Bruna Zanatta de Freitas, Francisco Costa Beber Lemanski, et al.
Arquivos de Neuro-Psiquiatria (2023) Vol. 81, Iss. 06, pp. 577-584
Open Access | Times Cited: 4
The influence of APOE status on rate of cognitive decline
Cassandra Morrison, Michael Oliver, Virginia Berry, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 3263-3274
Open Access | Times Cited: 1
Perceptions of precision medicine among diverse dementia caregivers and professional providers
Joseph E. Gaugler, Hayley R McCarron, Lauren Mitchell
Alzheimer s & Dementia Translational Research & Clinical Interventions (2019) Vol. 5, Iss. 1, pp. 468-474
Open Access | Times Cited: 10
<p>Pharmacogenomic Testing In Pediatrics: Navigating The Ethical, Social, And Legal Challenges</p>
Susanne B. Haga
Pharmacogenomics and Personalized Medicine (2019) Vol. Volume 12, pp. 273-285
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top